Let's see what they share with us in the next shareholder update - maybe there will some helpful into on the Omomyc issue. Cash runway is fine for now if you think there are further cash flows or value changing propositions in the pipeline this year - they could pull forward further R&D rebates in q3 if they are confident but it's a risky strategy - need to balance the interests of current shareholders and if they think there is value to be recognised or released in the next 6 months then you wait for those cash flows or news releases that re-rate the valuation before raising capital. If it were 5-10c now I'd encourage them to dilute 5-10% and raise $5m and I think they could unlock value in the next 6 months that gets them there (just my opinion - biased and not worth betting on).
PYC Price at posting:
2.4¢ Sentiment: Buy Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)